Knight Therapeutics Inc opened trading today at $5.23 and closed at $5.43. Intraday prices ranged from $5.23 to $5.49.

Shares advanced 3.43% from the previous day's close of $5.25.

Today across North America, the TSX Composite closed -0.19% at 21942.28, the S&P 500 closed -0.31% at 5218.19, the Dow Jones Industrial Average closed -0.41% at 39313.64 and the Nasdaq Composite closed -0.27% at 16384.47.

Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).

Trading volume was 127,669 on 405 total trades. On average, Knight Therapeutics Inc has traded 194,980 shares over 5 days and 79,723 year-to-date.

The TSX market on the whole today saw 2,365 price advancers against 2,885 declines and 121 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.75 (January 22,2024) and low as $4.28 (March 28,2023). Moreover, in the last 52 weeks, Knight Therapeutics Inc's shares have boosted 21.21 percent, while in 2024, they have advanced 4.62%.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $531.14 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Based on 4.00 analysts, Knight Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..